Tipsheet
What matters at India’s listed companies
Earnings · Medical Equipment · Micro cap

Kretto Syscon revenue halves as FY26 profit drops to ₹201.77 lakhs

The nano-cap firm confirmed audited results showing a sharp decline in annual performance, with Q4 slipping into a loss.

1 earlier story on Kretto Syscon Ltd.
Mkt cap₹38.61 cr
P/E19.13×
ROE6.09%
Debt / eq.0.01
₹589.89 lakhs Full-year revenue for FY26, down from ₹1,169.40 lakhs in FY25.

What's new

  • FY26 revenue fell to ₹589.89 lakhs from ₹1,169.40 lakhs in FY25.
  • Net profit dropped to ₹201.77 lakhs from ₹413.30 lakhs the prior year.
  • The company posted a Q4 loss of ₹38.84 lakhs.

Why this matters

The results confirm a material deterioration in the company's financial health. With revenue and profit both halving year-on-year, the transition to a quarterly loss reflects a business under pressure.

What we're watching

  • Any management commentary on the revenue decline.
  • Whether the company can return to profitability in FY27.
  • Liquidity levels for the ₹39 cr market-cap entity.

The full read

Kretto Syscon has confirmed its audited financials for FY26, revealing a sharp contraction across its business. Annual revenue fell to ₹589.89 lakhs from ₹1,169.40 lakhs in FY25, while net profit dropped to ₹201.77 lakhs from ₹413.30 lakhs.

The final quarter was particularly difficult, with the company posting a loss of ₹38.84 lakhs. These figures were previously disclosed, meaning this filing provides no new surprises for investors. The audit report carries an unmodified opinion.

For a company with a market capitalization of just ₹39 crore, the trend is clear: the business is shrinking rapidly.

It is a difficult result. The open question is whether this is a temporary setback or a structural decline that will persist into the coming quarters.

Questions answered

What were the key financial results for Kretto Syscon in FY26?
Revenue fell to ₹589.89 lakhs from ₹1,169.40 lakhs in FY25, while net profit dropped to ₹201.77 lakhs from ₹413.30 lakhs.
Did the company remain profitable in the final quarter?
No, the company reported a loss of ₹38.84 lakhs for Q4.
Is there any new information in this filing?
No. The core financial figures were previously disclosed, and this filing serves as a formal confirmation of the audited results.
What is the auditor's opinion on these results?
The audit report carries an unmodified opinion.
Mentioned: Kretto Syscon Ltd.
Primary source BSE · NSE · Tijori

An independent reading of the company's own disclosure — the primary filing above is the final word.

Company snapshot

Kretto Syscon Ltd.

Pharmaceuticals
₹40 cr
P/E 19.80×

Latest quarter · Mar 2026

Sales₹1 cr
Net profit−₹0 cr
Op. margin−35.8%
EPS−₹0.01

Strength & growth

Debt / equity0.01×
Current ratio7.22×
Sales CAGR−4.5%
EPS CAGR+16.9%
  1. 26 May 2026 · 7:28 PM IST Kretto Syscon revenue halves as FY26 profit drops to ₹201.77 lakhs
  2. 45d ago Kretto Syscon revenue halves as annual profit drops to ₹201.77 lakhs